"The centres, which were identified as part of G8’s ongoing portfolio review, are to be sold for ~$6.4
million, which equates to an FY19f EBIT multiple of c. 4.1x."
Is the 4.1 x EBIT the 'value' we should be ascribing to the value of G8.
ie what if we take G8 underlying 'ex covid' estimate of EBIT and multiply it by 4.1. What valuation would that give? Then subtract NET Debt and divide by shares on issue to get a 'value' share price.
Given this transaction was on a commercial basis, one would think this would give a lower end accurate value.
"The centres, which were identified as part of G8’s ongoing...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.010(0.86%) |
Mkt cap ! $902.7M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.17 | $1.15 | $4.420M | 3.783M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 149521 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 100276 | 6 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| GEM (ASX) Chart |